CVA Family Office’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.14K Buy
45
+35
+350% +$4.15K ﹤0.01% 1194
2026
Q1
$1.04K Buy
+10
New +$1.19K ﹤0.01% 1643
2023
Q3
– Sell
-23
Closed -$1.81K – 423
2023
Q2
$1.81K Buy
+23
New +$1.94K ﹤0.01% 894

Other funds holding DORM

CVA Family Office's DORM Position: Q2 2026 in Review

CVA Family Office increased its Dorman Products (DORM) stake by 350% in Q2 2026, buying an estimated $4.15K and bringing the position to 45 shares worth $6.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

CVA Family Office first reported a position in DORM in Q2 2023 and has held it in 3 quarters since. 329 funds tracked by Wall St. Rank hold DORM as of Q2 2026.

  • CVA Family Office held 45 shares of Dorman Products worth $6.14K as of Q2 2026.
  • CVA Family Office bought 35 Dorman Products shares in Q2 2026, an estimated $4.15K.
  • Dorman Products made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1194 holding.
  • CVA Family Office first reported a position in Dorman Products in Q2 2023 and has held it in 3 quarters since.
  • 329 funds tracked by Wall St. Rank held Dorman Products as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.